TPD & Induced Proximity Summit Leaderboard
  • Saturday, July 11, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

Oligonucleotides Analytical Development & CMC Summit Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Pharma Journalist
  • Page 453

Author

Pharma Journalist 8932 posts 0 comments

Catalent Launches OneXpress Solution to Accelerate Oral Dosage Products from Clinic to Launch

Oct 1, 2020
Catalent announced the launch of its new OneXpress service for the integrated development, scale up and manufacturing of new oral solid dosage forms. The OneXpress solution…
Read More...

Alnylam reports positive results from ILLUMINATE-B phase 3 study of Lumasiran

Oct 1, 2020
Alnylam Pharmaceuticals, Inc. announced positive topline results from the ILLUMINATE-B pediatric Phase 3 study of lumasiran, an investigational RNAi therapeutic targeting hydroxyacid…
Read More...

Covis Group Announces Agreement to Acquire AMAG Pharmaceuticals

Oct 1, 2020
Covis Group S.à r.l. and AMAG Pharmaceuticals, Inc. announced that they have entered into a definitive agreement under which Covis will acquire AMAG for $13.75 per share in cash, or…
Read More...

Sorrento Therapeutics and ViralClear Enter Into Agreement to Explore Combination Antibody Plus…

Oct 1, 2020
ViralClear Pharmaceuticals, Inc. and Sorrento Therapeutics, Inc. announced the companies are exploring the synergistic potential of small molecules and antibodies combination therapies…
Read More...

Eisai and Seikagaku Enter into Agreement for the Marketing Alliance of SI-613, a Treatment of…

Oct 1, 2020
Eisai Co., Ltd. and Seikagaku Corporation announced that the companies have entered into an agreement for the marketing alliance in South Korea for SI-613 (diclofenac conjugated sodium…
Read More...

Sermonix Pharmaceuticals Partners With Exactis Innovation for ELAINE 1 Clinical Trial Sites in…

Sep 30, 2020
Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company focused on the development of female oncology products in the precision medicine metastatic breast cancer…
Read More...

Kuur Therapeutics Announces First Patients Dosed with Allogeneic CAR-NKT Cell Therapy

Sep 30, 2020
Kuur Therapeutics, a leader in the development of off-the-shelf CAR-NKT cell immunotherapies for the treatment of hematological and solid malignancies, today announced the treatment of…
Read More...

CStone, Pfizer Enter into Strategic Collaboration to Address Oncological Needs in China

Sep 30, 2020
CStone Pharmaceuticals and Pfizer Investment Co. Ltd. and Pfizer Corporation Hong Kong Limited announced today the formation of a strategic collaboration that encompasses a $200 million…
Read More...

Vor Biopharma and Arbor Biotechnologies to Collaborate on Engineered Hematopoietic Stem-Cell…

Sep 30, 2020
Vor Biopharma, an oncology company pioneering engineered hematopoietic stem cells (eHSCs) for the treatment of cancer, and Arbor Biotechnologies, an early-stage life sciences company,…
Read More...

Orgenesis Announces Agreement to Acquire Koligo Therapeutics, a Leader in Personalized Cell…

Sep 30, 2020
Orgenesis Inc. and Koligo Therapeutics, Inc. announced that the two companies have entered into a definitive merger agreement, subject to final closing conditions, with expected…
Read More...
Prev Next
RNA-Based Therapeutics & Vaccines Summit South Korea
RNA-Targeted Drug Discovery & Development Summit
mRNA Process Development & CMC Summit 2026
TPD & Induced Proximity Summit
Measuring Patient Engagement Summit Europe
Oligonucleotides Analytical Development & CMC Summit
11th CAR-TCR Summit
COPD Drug Development Summit
2nd Operationalize: Expanded Access Programs Summit West
Neuropsychiatric Drug Development Summit
International Neoantigen Summit
Lab Ops & Facility Management for Biopharma West Summit
10th IPF Summit
Medical Device Software Development Summit
Liquid Biopsy for Precision Oncology Summit East Coast
ADC Linker & Conjugation Summit
Cell & Gene Therapy Summit South Korea
10th Dermatology Drug Development Summit
9th Lab Asset & Facility Management Summit
TRP Supply Chain & Manufacturing Summit
Covalent Drug Discovery & Development Summit
7th Genome Editing Therapeutics Summit
16th World Clinical Biomarkers & Companion Diagnostics Summit
Lipid Nanoparticles Development Summit Europe
iPSC Drug Development Summit
17th World ADC San Diego
Oligonucleotides for CNS Summit
In Vivo Cell Engineering & Gene Editing Summit
Obesity & Weight Loss Drug Development Summit
T-Cell Engager Therapeutics Summit
mRNA-Based Therapeutics Summit
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • Roche Receives CE Mark for Elecsys Latent TB Test
  • Teva Secures Global Rights to Polpharma’s Ocrevus Biosimilar
  • Samsung Bioepis Partners With Proteina on AI Antibody Drug Discovery
  • Evogene, Tel Aviv University Launch AI Drug Discovery Initiative
  • Wainua Misses Primary Endpoint in ATTR-CM Phase III Trial

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

Advancing Respiratory Medicine Following ATS – What Now?

World ADC San Diego Unveils Preliminary Agenda for 17th…

Regeneron Goes All In on Radiopharma with $2.1B Telix Deal…

IQ MPS Leaders to Share Industry Progress on Advancing In…

4th ADC Linker & Conjugation Summit Announces 2026…

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.